1. Home
  2. BGLC vs CMND Comparison

BGLC vs CMND Comparison

Compare BGLC & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • CMND
  • Stock Information
  • Founded
  • BGLC 2017
  • CMND 2017
  • Country
  • BGLC Malaysia
  • CMND Canada
  • Employees
  • BGLC N/A
  • CMND N/A
  • Industry
  • BGLC Medical Specialities
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGLC Health Care
  • CMND Health Care
  • Exchange
  • BGLC Nasdaq
  • CMND Nasdaq
  • Market Cap
  • BGLC 5.8M
  • CMND 6.0M
  • IPO Year
  • BGLC N/A
  • CMND N/A
  • Fundamental
  • Price
  • BGLC $0.25
  • CMND $1.03
  • Analyst Decision
  • BGLC
  • CMND
  • Analyst Count
  • BGLC 0
  • CMND 0
  • Target Price
  • BGLC N/A
  • CMND N/A
  • AVG Volume (30 Days)
  • BGLC 1.5M
  • CMND 55.0K
  • Earning Date
  • BGLC 05-14-2025
  • CMND 03-13-2025
  • Dividend Yield
  • BGLC N/A
  • CMND N/A
  • EPS Growth
  • BGLC N/A
  • CMND N/A
  • EPS
  • BGLC N/A
  • CMND N/A
  • Revenue
  • BGLC $9,259,858.00
  • CMND N/A
  • Revenue This Year
  • BGLC N/A
  • CMND N/A
  • Revenue Next Year
  • BGLC N/A
  • CMND N/A
  • P/E Ratio
  • BGLC N/A
  • CMND N/A
  • Revenue Growth
  • BGLC N/A
  • CMND N/A
  • 52 Week Low
  • BGLC $0.21
  • CMND $0.95
  • 52 Week High
  • BGLC $1.00
  • CMND $2.30
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 35.57
  • CMND 34.60
  • Support Level
  • BGLC $0.23
  • CMND $1.04
  • Resistance Level
  • BGLC $0.29
  • CMND $1.11
  • Average True Range (ATR)
  • BGLC 0.02
  • CMND 0.06
  • MACD
  • BGLC -0.01
  • CMND -0.00
  • Stochastic Oscillator
  • BGLC 20.22
  • CMND 10.07

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: